Previous studies including mainly adult IMNM patients showed that proportion of anti-HMGCR myopathy, anti-SRP myopathy and seronegative IMNM were 21.8–54%, 28.5–44%, and 13–40%, respectively (13–18). Here, HMGCR is linked to myopathy.